Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Berberis species, particularly Berberis vulgaris (barberry) and Berberis aristata, have been used traditionally in various systems of medicine for treating infections, and there is scientific evidence supporting their antibacterial activity. The primary active compound in Berberis is berberine, an isoquinoline alkaloid. In vitro studies have demonstrated that berberine possesses broad-spectrum antibacterial properties, inhibiting the growth of both Gram-positive and Gram-negative bacteria. These effects are thought to be due to berberine’s ability to disrupt bacterial cell walls, inhibit nucleic acid synthesis, and interfere with bacterial enzymes. Some studies have suggested potential synergy between berberine and conventional antibiotics, which may help counteract antibiotic resistance.

However, most of the supporting evidence comes from laboratory (in vitro) and animal studies, with relatively few well-designed human clinical trials evaluating the efficacy of Berberis or berberine for treating bacterial infections. While traditional use and laboratory research suggest potential benefits, more rigorous clinical research is needed to confirm its safety and effectiveness in humans for this purpose. Thus, the use of Berberis in bacterial infections is grounded in both traditional practices and preclinical scientific research, but clinical evidence in humans remains limited.

More about Berberis (unspecified)
More about Infection (bacterial)

Other ingredients used for Infection (bacterial)

Other health conditions supported by Berberis (unspecified)

Products containing Berberis (unspecified)